Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've missed three weeks of Mounjaro, the practical question is straightforward: because more than two weeks have passed since your last dose, your prescriber will likely advise treating the next injection as a restart rather than a continuation. That means returning to a lower dose, not picking up where you left off. This is a decision best made with your prescriber, who can review your individual history, current weight, and any symptoms before advising a path forward. Mounjaro (tirzepatide) is a prescription-only medicine, and any change to your dosing schedule should be clinically guided rather than self-managed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works by gradually changing the way your body responds to food and to gut hormones. The titration schedule, starting at 2.5mg and moving up in 4-week steps, exists precisely because the body needs time to settle. When you take a dose every week, that adaptation is maintained. After three weeks without a dose, those effects will have diminished considerably, and jumping back to the higher dose you were previously taking can make side effects far harder to manage than they were the first time around.
A question our prescribers hear most weeks is whether it's safe to simply resume the usual dose after a break. For a gap of this length, the honest answer is that it usually isn't the safest approach. The specific restart point depends on what dose you were taking, how long you had been on it, and how you're feeling now. That is a clinical call, not a rule that applies uniformly. The Mounjaro overview page has background on how tirzepatide works if it helps frame the decision.
The NHS tirzepatide guidance makes clear that patients should consult their prescriber if they miss a dose and are unsure how to proceed, particularly when the interval is extended. Restarting unsupervised at a maintenance dose after a three-week break carries real risks that a short conversation with your prescriber can help you avoid.
For most people who have missed three weeks, the likely advice is to return to the 2.5mg starting dose and work through the titration schedule again, though your prescriber may adjust this based on how you previously tolerated each step. Some people who reached higher doses with no significant side effects may be guided to restart one or two steps back rather than all the way to the beginning. There is no single protocol that fits everyone, which is why clinical review is not just a formality here.
If you had been stable on the 5mg dose, for instance, your prescriber might consider a different restart point than they would for someone who had reached 10mg or 12.5mg. Weight recorded before and after the gap may also inform what they recommend. The key practical point is not to self-prescribe a restart dose based on what felt comfortable before the break.
For context on what happened if you missed a shorter period, the guidance on missing Mounjaro for one week explains the principles that apply when the gap is closer to one weekly interval, and they differ from the three-week scenario in important ways.
Contact your prescriber before injecting again. That might be your GP, the prescribing team at your weight management service, or, if you're a private patient, the prescribers at your online pharmacy. Have to hand the dose you were last taking, the date of your last injection, and your current weight if you have it. Those three pieces of information make the restart conversation much quicker.
While you wait to hear back, it is worth reviewing the general missed Mounjaro dose guidance to understand the broader rules, and checking whether your situation overlaps with what applies after a two-week gap, since some of the same principles carry over. If the break happened because of a supply issue or a change in circumstances rather than a deliberate pause, that context is also useful to mention when you speak to your prescriber.
It's also worth knowing that re-starting at a lower dose and working back up does not mean starting from zero in terms of results. Many people find they return to their previous progress relatively quickly once the titration is complete. A gap, though not ideal, is not the end of the treatment journey.
Once your prescriber has confirmed a restart dose, the principles are the same as when you first began. Inject on the same day each week, rotate injection sites, keep the pen stored correctly (your Patient Information Leaflet gives the specific storage window for room temperature), and make a note in your calendar so the break doesn't repeat. If you found that gastrointestinal side effects were significant the first time around, expect that they may return briefly during re-titration and communicate with your prescriber if they feel unmanageable.
If, after restarting, progress feels slower than before or the dose that previously worked doesn't seem as effective, the page on what to do when tirzepatide doesn't seem to be working covers some of the reasons that can happen and what your prescriber might consider next. For a broader look at how the titration schedule fits into the full treatment picture, the guidance on a missed Mounjaro dosage gives useful background context.
If you're weighing up your options more broadly, including what private treatment costs and what's included in a full private prescription service, the Mounjaro pricing page explains how private treatment is structured. And when you're ready to speak with a prescriber about restarting, our clinical team can review your situation. Speak to our prescribers to get that conversation started. You can also find out more about who we are as a service if that helps you feel confident before making contact.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.